Encapsulation into hyaluronic acid-based nanogels improves the selectivity index of the snake cathelicidin Ab-Cath
Media Type: |
Electronic Article |
---|
Year of Publication: |
2023 |
---|---|
Publication: |
2023 |
Contained In: |
To Main Record - volume:52 |
---|---|
Contained In: |
Nanomedicine : nanotechnology, biology, and medicine - 52(2023) vom: 15. Aug., Seite 102694 |
Language: |
English |
---|
Contributors: |
van Gent, Miriam E [Author] |
---|
Links: |
---|
Notes: |
Date Completed 01.09.2023 Date Revised 27.09.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.nano.2023.102694 |
---|
funding: |
|
---|---|
Supporting institution / Project title: |
|
PPN (Catalogue-ID): |
NLM358953359 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM358953359 | ||
003 | DE-627 | ||
005 | 20231226075833.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.nano.2023.102694 |2 doi | |
028 | 5 | 2 | |a pubmed24n1196.xml |
035 | |a (DE-627)NLM358953359 | ||
035 | |a (NLM)37394107 | ||
035 | |a (PII)S1549-9634(23)00045-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a van Gent, Miriam E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Encapsulation into hyaluronic acid-based nanogels improves the selectivity index of the snake cathelicidin Ab-Cath |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.09.2023 | ||
500 | |a Date Revised 27.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a AMR infection | |
650 | 4 | |a Antimicrobial peptide Ab-Cath | |
650 | 4 | |a Drug delivery | |
650 | 4 | |a Lyophilization method | |
650 | 4 | |a Nanogel | |
650 | 7 | |a Cathelicidins |2 NLM | |
650 | 7 | |a Nanogels |2 NLM | |
650 | 7 | |a Hyaluronic Acid |2 NLM | |
650 | 7 | |a 9004-61-9 |2 NLM | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Kłodzińska, Sylvia N |e verfasserin |4 aut | |
700 | 1 | |a Severin, Maureen |e verfasserin |4 aut | |
700 | 1 | |a Ali, Muhanad |e verfasserin |4 aut | |
700 | 1 | |a van Doodewaerd, Bjorn R |e verfasserin |4 aut | |
700 | 1 | |a Bos, Erik |e verfasserin |4 aut | |
700 | 1 | |a Koning, Roman I |e verfasserin |4 aut | |
700 | 1 | |a Drijfhout, Jan Wouter |e verfasserin |4 aut | |
700 | 1 | |a Nielsen, Hanne M |e verfasserin |4 aut | |
700 | 1 | |a Nibbering, Peter H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nanomedicine : nanotechnology, biology, and medicine |d 2005 |g 52(2023) vom: 15. Aug., Seite 102694 |w (DE-627)NLM16062021X |x 1549-9642 |7 nnns |
773 | 1 | 8 | |g volume:52 |g year:2023 |g day:15 |g month:08 |g pages:102694 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nano.2023.102694 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 52 |j 2023 |b 15 |c 08 |h 102694 |